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The  serum  of  patients  with  malaria  has  not  been  shown  to  contain 
protective  antibodies  although  many investigators  have  felt  that  these 
immune substances should be present at some time during or following an 
acute infection.  This belief was given experimental support in  1937 by 
Coggeshall  and  Kumm  (1)  when they demonstrated that  the  serum of 
rhesus monkeys with chronic Plasmodium knowlesi infections conferred a 
passive immunity upon normal monkeys.  Mosna (2) in 1938 repeated the 
work with essentially the same results.  Hegner and Eskridge  (3),  using 
the concentrated serum of canaries immune to Plasmodium cathemerium, 
attempted to produce a passive immunity in normal birds and concluded 
that an  alleviation of symptoms resulted although no  diminution of the 
intensity of infections was noted.  Manwell and Goldstein (4) conclusively 
demonstrated the inhibitory effect of immune serum on Plasmodium cir- 
cumflexum  infections  when  used  in  a  protection  test.  More  recently 
Taliaferro and Taliaferro (5) have shown that the intensity of Plasmodium 
Iophurae infections in  chicks can be  diminished by homologous immune 
serum administered daily throughout the course of the acute infection, and 
that incubation of immune serum and parasitized red cells  at  37°C. for 
2 hours greatly enhanced the protective action of the immune serum. 
Unfortunately, there remain difficulties in testing the protective property 
of human serum in experimental animals by the methods used in the studies 
mentioned above.  In the first place, the plasmodia which naturally infect 
man are not known to be pathogenic for any lower vertebrate host and, 
therefore, are not readily adaptable for use in protection tests.  Secondly, 
the lack of available non-immune volunteers or paretics who could be in- 
oculated with malaria under controlled conditions presents almost insur- 
mountable difficulties in a protection test confined solely to human beings. 
Finally, the great amount of immune serum necessary to  demonstrate a 
definite protective effect in monkeys on the basis of body weight would 
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eliminate  the  repetition  of the  experiment  in man,  assuming  that  the pro- 
portions were similar in both instances.  However, a  method for extending 
the  study  of humoral  immunity  to  malaria  in  man  was  suggested  by  the 
work  of  Knowles  and  Das  Gupta  (6)  who  succeeded  in  producing  an  in- 
fection with P. knowlesi in three human  volunteers.  Thus serum obtained 
from patients  with induced  knowlesi malaria  could be  tested  for protective 
antibodies  in  rhesus  monkeys.  The  same  specimens  could  also  be  tested 
for  the  presence  of  agglutinins  and  complement-fixing  antibodies.  Ac- 
cordingly, experiments  were made  using serum from patients  with induced 
knowlesi  malaria  in  an  attempt  to  demonstrate  the  existence  of  humoral 
immune  substances. 
Methods 
The source of the serum was one Negro patient at the New York HospitaP and six 
Negro patients  at  the  Manhattan  State  Hospital, 1 all  suffering from general paresis. 
Two had previously been found resistant to infection with vivax malaria when inoculated 
for therapeutic purposes.  The patients were bled for serum and then inoculated intra- 
venously or intramuscularly  with  1  to  5  cc.  of citrated  blood from a  rhesus  monkey 
after tests showed that the animal was suffering from no infection other than P. knowlesi 
malaria.  The patients were then bled at various intervals after recovery from the acute 
attack. 
Protection Tests.--The protection tests with human serum were done by the method 
of Coggeshall and Kumm (7)  with certain modifications aimed at  increasing the  sen- 
sitivity of the test.  These modifications were the result of a previous study by Cogge- 
shall and Eaton (8)  which showed that the effectiveness of an immune serum was pro- 
portional to the number of parasites in the inoculum when incubated together 30 minutes 
at 37°C. before injection.  The test used in the present study consisted of mixing 2 cc. 
of  the  immune  serum  with  10,000  P.  knowlesi  parasites,  incubation  at  37°C.  for 30 
minutes, and the injection of The mixture intra-abdominally into normal rhesus monkeys. 
In certain  instances  there  was  no further  administration  of immune  serum,  while  in 
others subsequent injections were made.  In order to determine the protective property 
of any particular serum sample, either the amount of serum or the number of parasites 
in the inoculum was varied. 
Complement Fixation  Tests.--The  sera  of six patients  were  tested  for the presence 
and concentration of complement-fixing antibodies according to the method described 
by  Eaton  and  Coggeshall  (9),  in  which  saline  extracts  of concentrated  P.  knowlesi 
parasites  were used for antigens. 
Agglutination  Tests.--Using the method of Eaton (10), attempts were made to deter- 
mine the agglutinating titer of the same samples of serum used in the protection tests. 
The  concentration  of  protective  antibodies  and  agglutinins  seemed  to  parallel  each 
other;  however, as the presence of heteroagglutinins  seriously interfered with the tests 
1 We wish to acknowledge the cooperation of Dr. W. McDermott at the New York 
Hospital and Dr. Ernest Kusch at the Manhattan State Hospital who were responsible 
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even after absorption, no  definite  conclusions  could  be drawn  and  the  data  are  not 
included. 
EXPERIMENTAL 
Protection  Test  /.--Protection  tests  were made on  specimens of  serum  of patient 
W.  F.  who was inoculated  intramuscularly with 2,000,000  P.  knowlesl  parasites, and 
the onset of clinical  activity occurred  12 days later as evidenced by a  fever of 38°C. 
There  were  six  daily  paroxysms,  and  the  acute  disease  terminated  spontaneously. 
The maximum temperature during this period reached 39.4°C., and the greatest number 
of  circulating  parasites  was  184  per  10,000 red  blood  cells.  Serum  specimens were 
obtained at the time of inoculation, as well as 4 and 66 days after the acute disease had 
subsided.  The protection tests were  carried out  with these specimens using 2 cc.  of 
serum  and  10,000 parasites.  The  specimen  obtained  before  infection  and  another 
TABLE  I 
Results of Protection Tests with Specimens  of Serum from Patient W. F. 
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Died 13th day 
from a  normal individual  served  as  controls.  Each  of the  two  specimens of  serum 
collected  during convalescence  was tested in two monkeys.  One of each pair received 
only the 2 cc. of immune serum in the inoculum, while the duplicate received 2 cc. of 
immune serum daily for 10 days. 
The  results,  which  are  summarized  in  Table  I,  show  that  monkey  1, 
which  received  the  preinfection  serum  specimen,  and  monkey  6,  which 
received normal human serum, died on the  14th day and  13th day, respec- 
tively.  Of the  four remaining animals in which  the  convalescent sera were 
tested, monkey 2 developed no infection, while monkeys 3, 4, and 5 became 
infected  but  survived.  The  20  cc.  of  the  66-day  serum given to  monkey 
5 in addition  to that contained in the original inoculum apparently slightly 
diminished  the intensity of the infection as compared with that of monkey 
4.  The  results  indicate  that  the  serum  from  this  patient  had  acquired 
protective  antibodies  in  demonstrable  concentration  in  the  course  of  the 
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Protection  Test  2.--Protection and  complement fixation  tests  were  made  on  the 
serum specimens of patient T. H. who had been inoculated intramuscularly with 3,500,00 
P. knowlesi parasites.  The first sign of infection was a mild prodromal fever followed 
by a  severe  paroxysm and  temperature of 40°C.  on  the  llth  day after inoculation. 
During the acute course of the disease which lasted 7 days there was a maximum tem- 
perature of 42°C.,  and  the infection terminated spontaneously.  The number of cir- 
culating  parasites  paralleled  the  fever curve,  the  greatest  concentration  being  306 
parasitized cells per 10,000 normal red blood cells.  The blood smears became negative 
soon after the temperature assumed a normal level and there were no relapses.  A sample 
of serum was obtained before inoculation,  at the height of the acute disease, and at 27 
and 102 days after termination of the acute attack.  These four specimens were tested 
simultaneously  in individual normal monkeys for their protective effect. 
The results  are  shown  in  Table  II.  It  will  be  seen  that  no  protective 
effect was  demonstrable  with  specimens  taken  before inoculation,  at  the 
TABLE II 
Results of Protection and Complement Fixation Tests with Specimens  of Serum from 
Patient T. H. 
Monkey  Serum obtained after termination  Result  Complement fixation 
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height of th~ acute attack, or in early  convalescence.  On  the other hand, 
monkey 10, which received the serum obtained 102 days after the patient's 
recovery,  survived  the  infection.  The  survival  of  this  monkey  further 
indicates  the  existence in  the  patient  of  a  subclinical  infection with  the 
gradual  accumulation  of  protective  antibodies.  An  example  of  such  an 
infection has been recorded by Milam and Coggeshall (11) where a patient 
after  a  spontaneous  recovery from induced  knowlesi  malaria  had  normal 
temperatures and negative daily  thick blood smears for 130 days, yet the 
blood was  infectious for  monkeys when  subinoculated  at  that  time. 
The results of the complement  fixation tests paralleled those of the pro- 
tection test.  The greatest  concentration of complement-fixing antibodies 
was  present  in  the  serum  that  exerted  the  maximum  protective  ability. 
Protection  Test  3.--Protection and  complement fixation  tests  were  made  on  the 
serum specimens of patient R. G., who had been inoculated intravenously with 3,000,000 
P.  knowlesi  parasites.  An  elevation of temperature occurred 3  days later and  was 
followed by six daily paroxysms with a maximum temperature of 41.2°C.  The acute L.  T.  COGGESHALL  25 
disease terminated spontaneously and  no  relapses were  noted.  Serum  was  obtained 
before inoculation and 8, 28, and 56 days after clinical activity had subsided.  The three 
specimens of serum taken from this patient during convalescence were tested in duplicate 
for their protective properties in six different monkeys; three received only the inoculum 
which consisted of 2  cc.  of immune  serum  and  10,000  parasites while the  duplicates 
received an identical inoculum and an additional 1 cc. daily of the same immune serum 
beginning the day that parasites were first detected in the blood smears.  The results of 
these tests are shown in Table III. 
It will be seen in Table III that a definite protective effect was obtained 
with the serum specimens obtained 8 and 28 days after the acute attack. 
There was no real evidence which showed that the injection of additional 
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serum had influenced the course of the infection in the test animals.  The 
reason for the failure of monkeys 11,  13, and 16 to become infected is not 
known.  It was observed that the  serum from this patient agglutinated 
normal monkey red cells in  extremely high dilutions, which may offer a 
possible explanation.  The complement fixation test,  also  shown in Table 
III,  reveals that the maximum titer of complement-fixing antibodies was 
obtained with the sample of serum obtained 8 days after the acute attack 
had subsided.  The 8-day specimen also exhibited the greatest protective 
effect.  Thus it was seen that this patient had a definite serological immune 
response following  the  attack of induced malaria. 
Protection Test 4.--As the serum obtained from patient R.  G. on the 8th day after 
the acute infection had terminated had the greatest protective ability, it  was  decided 
to  test  this specimen further  by determining the  protective antibody titer against a 26  MALARIA  ANTIBODIES  IN  HUMAN  SERUM 
varying number of parasites.  Accordingly the 2 cc. samples of the serum were incubated 
with  1,000,000,  100,000,  10,000, and  1000 parasites,  respectively, and  each mixture 
was injected into individual monkeys.  One control monkey received 2 cc. of normal 
human serum and 10,000 parasites. 
The results are shown in Table IV, and it was found that  the length of 
disease increased as the number of parasites was decreased in the inoculum. 
As the amount of immune serum was kept constant, these results are taken 
to indicate a definite protective effect.  The failure of monkey 22 to survive 
when  the  dose of parasites was only  1000  does not  invalidate  the  general 
result. 
TABLE  IV 
Titration of Protective Effect witk 2 Cc. Serum of Patient R. G. Taken 8 Days after Recovery 
from Acute Attack 











Died llth day 
Died 13th day 
No infection 
Died 15th day 
Died llth day 
* Normal human serum. 
Protection Test 5.--Serum specimens were obtained for protection and complement 
fixation tests on patient B. A. who was inoculated intravenously with 1 cc. of infected 
blood containing approximately 10,000,000 P. knowlesi  parasites.  Clinical  activity of 
the infection was mild, 5 days in duration, and terminated spontaneously.  The maxi- 
mum parasite count was 30 per 10,000 red cells.  Serum samples were taken on 5,  17, 
and 53 days, respectively, after the acute attack had subsided and were tested in  the 
same manner as was the serum of Protection Test 3. 
The results shown in Table V indicate that the serum of this patient, who 
experienced  an  abortive  clinical  attack,  showed  a  slight  protective  effect. 
Supplementary  serum injections  into  monkeys  25  and  29 were  associated 
with more prolonged infections than were obtained in monkeys 24 and 28, 
which  received  no  additional  serum,  and  all  of  the  test  monkeys  which 
became infected lived longer than the control which received normal human 
serum.  The maximum complement fixation titer was 1:8,  which is a  rela- 
tively low level. 
Protection  Test  6.--In order to obtain specimens  of serum for protection and com- 
plement fixation tests, patient T. M. was inoculated intramuscularly with 1 cc.  of in- L.  T.  COOGESHALL  27 
fected blood containing 3,000,000 P.  knowlesi parasites.  The  incubation  period was 
23 days.  The acute disease lasted only 4 days and was extremely mild, with a maximum 
parasite count of 3 per 10,000  red cells.  The acute infection terminated spontaneously. 
A preinoculation serum specimen was obtained and also specimens 10 and 36 days after 
the patient's temperature had  returned  to  a  normal level.  The serum was  tested in 
TABLE  V 
Results  of  Protection  and  Complement  Fixation  Tests  with  Specimens  of Serum from 
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TABLE  VI 
Results  of  Protection  and  Complement Fixation  Tests  with  Specimens  of Serum from 
Patient  T. M. 
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monkeys 31,  32,  and  33  as  in  Protection  Test  3,  and  the  results are summarized  in 
Table  VI. 
The fact that monkey  33 had a  milder infection and survived longer than 
monkeys 31  and 32 is indicative of a  stronger protective effect of the serum 
obtained 36 days after the termination of the acute attack  than  that of the 
preinoculation  sample or  the  one  taken  at  the  height  of  the  disease.  In 
this instance the serum with the maximum  titer of complement-fixing anti- 28  MALARIA  ANTIBODIES  IN HUMAN  SERUM 
bodies apparently did not coincide with that showing the greatest protective 
effect. 
Protection  Test  7.--Protection  and  complement fixation  tests  were  made  on  the 
serum  specimens  of  patient  L.  B.  The  inoculation  was  made  intravenously  with 
18,000,000 P. knowlesi parasites, and parasites were first noted in the blood smears 10 
days later,  also  the  day of clinical  onset.  The acute  disease  lasted  5  days and  the 
maximum temperature was 40.8°C.  Only one convalescent serum specimen was taken 
after the temperature had returned  to a  normal level.  Since  there was only a  single 
postinfection sample of serum obtained 16 days after the acute attack  had  spontane- 
ously subsided,  its protective qualities were compared to the one taken before inoculation, 
and a normal monkey serum control was added.  The infecting dose of parasites for the 
protection tests was reduced to 1000 in these tests. 
The results in Table VII show that the incubation of 4 cc. of the patient's 
serum obtained before the malaria infection exerted no inhibitory effect on 
TABLE  VII 
Results  of Protection and  Complement Fixation  Tests  with  Specimens  of Serum from 
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the  disease  of monkey 35.  The use of  an equal  amount  of  convalescent 
serum  and  1000  parasites  resulted  in  a  mild  infection  and  survival  when 
injected  into  monkey 36.  Monkey  37,  which  received  1  cc.  of  the  same 
serum and 1000 parasites, had a  prolonged infection and succumbed on the 
14th  day.  The  additional  control  monkey  38  had  a  typical  P.  knowtesi 
infection  and died on the  11th  day.  Complement fixation tests showed a 
substantial  titer of antibodies,  1:12  in the postinfection  sample  of  serum. 
Protection Test 8.--As a check on previous experiments in which it had been noted 
that  the sera of certain patients during convalescence  had a  greater protective effect 
than those of others, it was decided to combine the remaining portions of the stronger 
specimens into pool 1 and compare its inhibitory action with that of pool 2, which was 
a mixture of those sera showing  little or no activity when used in a protection experi- 
ment.  The sera from these pools were tested in the usual manner for the presence of 
protective antibodies, and in addition an attempt was made to determine whether or L.  T.  COGGESHALL  29 
not the incubation of the serum with the inoculating dose of parasites influenced the 
course of the infection in the test. 
The results of this experiment, summarized in Table VIII, showed that 
monkey 39 was able to recover from its infection with the aid of the serum 
from pool 1, which was the more potent of the two pools.  It was also in- 
dicated that the incubation of the immune serum and the parasites was a 
deciding factor in  the favorable outcome of the infection in monkey 39, 
although  this  cannot be  given  too  much  credit because  monkey 40  de- 
TABLE  VIII 
Protection Tests with Pool  1 and  Pool 2 Serum with and  without  Incubation  with 1000 
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Died 13th day 
Died 14th day 
Died 14th day 
veloped  a  severe  hemoglobinuria,  and  this  complication  usually  results 
fatally for the monkey. 
DISCUSSION 
That protective antibodies are found in the serum of animals following 
recovery from an acute attack of malaria is no longer doubted.  In addition 
to the demonstration of the existence of these immune substances, it has 
been  consistently pointed out  that  their  concentration is  extremely low. 
Actually this conclusion may be unjustified.  The protection tests against 
some bacteria and viruses, involving the use of mice in large numbers, have 
reached such a  high degree of refinement that the potency of the immune 
serum can be measured quantitatively in terms of the number of infective 
or lethal doses of the specific agent neutralized by a  given quantity of the 
serum.  No such test is  practical in malaria.  In testing an intracellular 
parasite  such as  the malaria plasmodium against its  antiserum,  it is  ap- 
parent that a  situation different from that of bacteria or viruses prevails. 
Presumably, the parasite in the inoculum is protected by a cell membrane 
which prevents an intimate contact between the organism and the immune 
serum.  This inference has considerable basis in fact; for example, Eaton 
(10) has shown that an immune serum will agglutinate the malaria parasite 
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destroyed, or at  least  very permeable.  The  same serum was ineffective 
against  the  young ring  or  ameboid forms of  the  parasite.  Likewise,  in 
unpublished studies,  it has been found in this laboratory that an immune 
serum in vitro  is more  effective against  an  equal  number  of  segmenting 
forms than against young rings, although the former multiply within a  few 
minutes  into  approximately  16  times  more  parasites.  This  indicates  a 
greater protective effect by reason of accessibility of the immune serum to 
the parasite.  Such a situation would explain why the results of the malaria 
protection tests in birds and monkeys are frequently indefinite; also why 
so  many of  the  earlier experiments in  passive  immunity were negative. 
The parasite may be shielded from the action of immune serum not only 
during its  growth within  the  red cell, but  likewise throughout its  entire 
cycle of  development.  It  may be  held  that  the  opportunity  for  union 
between antigen and antibody would occur at  the  time the parasite  spor- 
ulates, but just where this phenomenon takes place in the host is not known. 
In all probability the parasite either rapidly invades a new red cell outside 
the  freely  circulating  blood  or  is  phagocytized  by  a  macrophage.  In 
intense P. knowlesi infections one may obtain more than 50 per cent of red 
cells infected with mature segmenting  forms  and  find only an  occasional 
free parasite even when the animal's blood is examined at short  intervals 
throughout  the  entire period of  sporulation.  It  seems probable  that  in 
blood smears most, if not all, of the free merozoites seen outside  the  red 
cell  are  the  result  of  mechanical  disruption.  Furthermore,  Eaton  and 
Coggeshall (12)  showed that an anti-monkey red cell serum lysed infected 
red cells and rendered the liberated parasites non-infectious.  This indicates 
that the free malaria parasites within the peripheral blood stream are prob- 
ably not associated with,  or essential to,  the natural  course  of infection. 
Another indication that the parasite is protected from  the  action of an 
immune serum is that in chronic P. knowlesi infections one is  able  to find 
a  rather constant number of circulating parasites in  a  serum that  can be 
shown to possess a  relatively high concentration of protective antibodies. 
The observations cited, as well as many others, may explain why the results 
of the malaria protection tests cannot be compared with those obtained in 
many other diseases.  Therefore, it would seem more logical to assume that 
the protection tests with malaria immune serum as used are inadequate to 
demonstrate the actual titer of protective antibodies which may be present 
in a considerable concentration.  From the same evidence it can be assumed 
that immunity in malaria is relatively ineffective and temporary, not be- 
cause the immune substances are present in low concentration, but because 
they are  unable  to  exert their maximum influence, either directly or in- 
directly, against  the parasite. L. T.  COGGESHALL  31 
The results of the complement fixation tests may be  discussed briefly. 
In  all  instances  the preinoculation samples of  sera were  negative,  while 
the  convalescent specimens contained varying  concentrations of  comple- 
ment-fixing substances.  There was no uniform correlation between their 
titer and protective action of the serum.  Although there is no evidence to 
indicate  that  complement-fixing antibodies  and  protective antibodies  are 
identical substances, they are both produced as a result of malaria infection. 
In the preceding experiments it is to be noted that none of the patients 
experienced a  clinical attack which persisted longer than  7  days.  Also, 
all  infections subsided  without  the  aid  of  any  treatment.  This  type of 
infection is commonly observed in Negroes, who have a marked resistance 
to P. knowlesi infections as compared with white persons.  A more definite 
protective effect might have been obtained with immune serum taken from 
individuals more susceptible to this parasite. 
SUMM  ARY 
Evidence  has  been  presented  which  indicates  that  antibodies  appear 
in  the  serum of individuals  following an  induced malaria  infection with 
Plasmodium  knowlesi. 
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